Digitalni repozitorij raziskovalnih organizacij Slovenije

Iskanje po repozitoriju
A+ | A- | Pomoč | SLO | ENG

Na voljo sta dva načina iskanja: enostavno in napredno. Enostavno iskanje lahko zajema niz več besed iz naslova, povzetka, ključnih besed, celotnega besedila in avtorja, zaenkrat pa ne omogoča uporabe operatorjev iskanja. Napredno iskanje omogoča omejevanje števila rezultatov iskanja z vnosom iskalnih pojmov različnih kategorij v iskalna okna in uporabo logičnih operatorjev (IN, ALI ter IN NE). V rezultatih iskanja se izpišejo krajši zapisi podatkov o gradivu, ki vsebujejo različne povezave, ki omogočajo vpogled v podroben opis gradiva (povezava iz naslova) ali sprožijo novo iskanje (po avtorjih ali ključnih besedah).

Pomoč
Išči po:
Možnosti:
 


61 - 70 / 2000
Na začetekNa prejšnjo stran3456789101112Na naslednjo stranNa konec
61.
Impact of COVID-19 on cancer diagnosis and management in Slovenia : preliminary results
Vesna Zadnik, Ana Mihor, Sonja Tomšič, Tina Žagar, Nika Bric, Katarina Lokar, Irena Oblak, 2020, izvirni znanstveni članek

Ključne besede: covid-19, oncology, oncology diagnosis, pandemic
Objavljeno v DiRROS: 12.07.2024; Ogledov: 57; Prenosov: 33
.pdf Celotno besedilo (291,69 KB)
Gradivo ima več datotek! Več...

62.
Care of patients with non-small-cell lung cancer stage III : the Central European real-world experience
Milada Zemanova, Robert Pirker, Luboš Petruželka, Zuzana Zbozínkova, Mirjana Rajer, Krisztina Bogos, Gunta Purkalne, Vesna Ceriman, Subhash Chaudhary, Igor Richter, 2020, izvirni znanstveni članek

Povzetek: Background. Management of non-small-cell lung cancer (NSCLC) is affected by regional specificities. The present study aimed at determining diagnostic and therapeutic procedures including outcome of patients with NSCLC stage III in the realworld setting in Central European countries to define areas for improvements. Patients and methods. This multicentre, prospective and non-interventional study collected data of patients with NSCLC stage III in a web-based registry and analysed them centrally. Results. Between March 2014 and March 2017, patients (n=583) with the following characteristics were entered: 32% females, 7% never-smokers; ECOG performance status (PS) 0, 1, 2 and 3 in 25%, 58%, 12% and 5%, respectively; 21% prior weight loss; 53% squamous carcinoma, 38% adenocarcinoma; 10% EGFR mutations. Staging procedures included chest X-ray (97% of patients), chest CT (96%), PET-CT (27%), brain imaging (20%), bronchoscopy (89%), endobronchial ultrasound (EBUS) (13%) and CT-guided biopsy (9%). Stages IIIA/IIIB were diagnosed in 55%/45% of patients, respectively. N2/N3 nodes were diagnosed in 60%/23% and pathologically confirmed in 29% of patients. Most patients (56%) were treated by combined modalities. Surgery plus chemotherapy was administered to 20%, definitive chemoradiotherapy to 34%, chemotherapy only to 26%, radiotherapy only to 12% and best supportive care (BSC) to 5% of patients. Median survival and progression-free survival times were 16.8 (15.3;18.5) and 11.2 (10.2;12.2) months, respectively. Stage IIIA, female gender, no weight loss, pathological mediastinal lymph node verification, surgery and combined modality therapy were associated with longer survival. Conclusions. The real-world study demonstrated a broad heterogeneity in the management o f stage III NSCLC in Central European countries and suggested to increase the rates of PET-CT imaging, brain imaging and invasive mediastinal staging.
Ključne besede: diagnostic procedures, multimodality treatment, non-small-cell cancer, lung cancer
Objavljeno v DiRROS: 12.07.2024; Ogledov: 48; Prenosov: 28
.pdf Celotno besedilo (985,32 KB)
Gradivo ima več datotek! Več...

63.
64.
Percutaneous image guided electrochemotherapy of hepatocellular carcinoma : technological advancement
Mihajlo Djokić, Rok Dežman, Maja Čemažar, Miha Štabuc, Miha Petrič, Lojze Šmid, Rado Janša, Boštjan Plešnik, Maša Omerzel, Urša Lampreht Tratar, Blaž Trotovšek, Bor Kos, Damijan Miklavčič, Gregor Serša, Peter Popović, 2020, izvirni znanstveni članek

Povzetek: Background. Electrochemotherapy is an effective treatment of colorectal liver metastases and hepatocellular carcinoma (HCC) during open surgery. The minimally invasive percutaneous approach of electrochemotherapy has already been performed but not on HCC. The aim of this study was to demonstrate the feasibility, safety and effectiveness of electrochemotherapy with percutaneous approach on HCC. Patient and methods. The patient had undergone the transarterial chemoembolization and microwave ablation of multifocal HCC in segments III, V and VI. In follow-up a new lesion was identified in segment III, and recognized by multidisciplinary team to be suitable for minimally invasive percutaneous electrochemotherapy. The treatment was performed with long needle electrodes inserted by the aid of image guidance. Results. The insertion of electrodes was feasible, and the treatment proved safe and effective, as demonstrated by control magnetic resonance imaging. Conclusions. Minimally invasive, image guided percutaneous electrochemotherapy is feasible, safe and effective in treatment of HCC.
Ključne besede: electrochemotherapy, hepatocellular carcinoma, percutaneous, minimally invasive
Objavljeno v DiRROS: 12.07.2024; Ogledov: 61; Prenosov: 11
.pdf Celotno besedilo (1,52 MB)

65.
Sorafenib for the treatment of hepatocellular carcinoma : a single-centre real-world study
Jurij Hanžel, Tajda Božič, Borut Štabuc, Rado Janša, 2020, izvirni znanstveni članek

Povzetek: Background Sorafenib is an oral multi-kinase inhibitor used for the treatment of hepatocellular carcinoma. Its efficacy in randomised controlled trials was demonstrated in patients with well-preserved liver function and good functional status. In the real-world setting, treatment is often offered to patients outside these criteria. We therefore performed a single-centre real-world cohort study on the efficacy of sorafenib in patients with hepatocellular carcinoma. Patients and methods We identified all patients with hepatocellular carcinoma initiating treatment with sorafenib between January 2015 and January 2018. The primary endpoint was overall survival (OS) since starting sorafenib. Clinical and demographic variables associated with survival were studied. Results The median OS was 13.4 months (95% CI 8.2%18.6). Multivariable Cox%s regression identified worse ECOG performance status (HR 2.21; 95% CI 1.56%3.16; P < 0.0001), Child-Pugh class C (HR 52.4; 95% CI 3.20%859; P = 0.005) and absence of prior locoregional treatment (HR 2.30; 95% CI 1.37%3.86; P = 0.002) to be associated with increased mortality. Conclusions Careful selection of patients for treatment with sorafenib is of paramount importance to optimize outcomes.
Ključne besede: hepatocellular carcinoma, survival, sorafenib
Objavljeno v DiRROS: 12.07.2024; Ogledov: 56; Prenosov: 29
.pdf Celotno besedilo (583,71 KB)
Gradivo ima več datotek! Več...

66.
Diagnostic accuracy of (1-3)-[beta]-D-glucan to predict Pneumocystis jirovecii pneumonia in non-HIV-infected patients
Petra Rogina, Miha Skvarč, 2020, izvirni znanstveni članek

Povzetek: Background Pneumocystis jirovecii pneumonia (PCP) is a common and potentially fatal opportunistic infection in immunocompromised non-HIV individuals. There are problems with clinical and diagnostic protocols for PCP that lack sensitivity and specificity. We designed a retrospective study to compared several methods that were used in diagnostics of PCP. Patients and methods One hundred and eight immunocompromised individuals with typical clinical picture for PCP and suspicious radiological findings were included in the study. Serum samples were taken to measure the values of (1-3)-[beta]-D-glucan (Fungitell, Associates of Cape Cod, USA). Lower respiratory tract samples were obtained to perform direct immunofluorescence (DIF, MERIFLUOR Pneumocystis, Meridian, USA) stain and real-time PCR (qPCR). Results Fifty-four (50%) of the 108 patients in our study had (1-3)-[beta]-D-glucan > 500 pg/ml. Patients that had (1-3)-[beta]-D-glucan concentrations < 400 pg/ml in serum, had mean threshold cycles (Ct) 35.43 +- 3.32 versus those that had (1-3)-[beta]-D-glucan concentrations >400 pg/mL and mean Ct of 28.97 +- 5.27 (P < 0.001). If we detected P. jirovecii with DIF and qPCR than PCP was proven. If the concentration of (1-3)-[beta]-D-glucan was higher than 400 pg/ml and Ct of qPCR was below 28.97 +- 5.27 than we have been able be certain that P. jirovecii caused pneumonia (odds ratio [OR] 2.31, 95% confidence interval [CI] 1.62-3.27, P < 0.001). Conclusions Measurement of (1-3)-[beta]-D-glucan or qPCR alone could not be used to diagnose PCP. Diagnostic cut-off value for (1-3)-[beta]-D-glucan > 400pg/ml and qPCR below 30 Ct, allow us to conclude that patient has PCP. If the values of (1-3)-[beta]-D-glucan are < 400 pg/ml and qPCR is above 35 Ct than colonization with P. jirovecii is more possible than PCP.
Ključne besede: Pneumocystis jirovecii pneumonia, real-time PCR, non-HIV-infected patients
Objavljeno v DiRROS: 12.07.2024; Ogledov: 52; Prenosov: 31
.pdf Celotno besedilo (594,98 KB)
Gradivo ima več datotek! Več...

67.
Mechanical recanalization for acute bilateral cerebral artery occlusion - literature overview with a case
Miran Jeromel, Zoran Miloševič, Janja Pretnar-Oblak, 2020, pregledni znanstveni članek

Povzetek: Background. Acute bilateral internal carotid artery (ICA) and/or middle cerebral artery (MCA) occlusion is extremely rare and associated with poor clinical outcomes. There are only a few reports in the literature about mechanical thrombectomy being performed for acute bilateral occlusions. The treatment strategies and prognoses (clinical outcomes) are therefore unclear. Methods. A systematic review of the literature was performed through several electronic databases with the following search terms: acute bilateral stroke, mechanical recanalization and thrombectomy. Results. In the literature, we identified five reports of six patients with bilateral ICA and/or MCA occlusion treated with mechanical recanalization. Additionally, we report our experience with a subsequent contralateral large brain artery occlusion during intravenous thrombolytic therapy, where the outcome after mechanical thrombectomy was not dependent on the time from stroke onset but rather on the capacity of collateral circulation exclusively. Conclusions. Acute bilateral cerebral (ICA and/or MCA) occlusion leads to sudden severe neurological deficits (comas) with unpredicted prognoses, even when mechanical recanalization is available. As the collateral capacity seems to be more important than the absolute time to flow restoration in determining the outcomes, simultaneous thrombectomy by itself probably does not lead to improved functional outcomes.
Ključne besede: acute bilateral stroke, mechanical recanalization, thrombectomy
Objavljeno v DiRROS: 12.07.2024; Ogledov: 54; Prenosov: 28
.pdf Celotno besedilo (624,29 KB)
Gradivo ima več datotek! Več...

68.
Studying cell death initiation using a digital microscope
Tina Arnšek, Nuša Golob, Nastja Marondini, Maruša Pompe Novak, Kristina Gruden, Tjaša Lukan, 2023, izvirni znanstveni članek

Povzetek: Hypersensitive response (HR)-conferred resistance is an effective defense response that can be determined by the N resistance genes. HR is manifested as the formation of cell death zones on inoculated leaves. Here, a protocol for studying the rate of cell death initiation by imaging inoculated leaves in the time between the cell death initiation and the cell death appearance using a digital microscope is presented. The digital microscope enables a continuous imaging process in desired intervals, which allows an accurate determination of cell death initiation rate up to minutes exactly, as opposed to hours in traditional methods. Imaging with the digital microscope is also independent of light and can therefore be used during day and night without disturbing the circadian rhythm of the plant. Different pathosystems resulting in programmed cell death development could be studied using this protocol with minor modifications. Overall, the protocol thus allows simple, accurate, and inexpensive identification of cell death initiation rate.
Ključne besede: digital microscope, cell death, inoculated leaves
Objavljeno v DiRROS: 12.07.2024; Ogledov: 66; Prenosov: 29
.pdf Celotno besedilo (1,13 MB)
Gradivo ima več datotek! Več...

69.
70.
New records of rarely reported species in the Mediterranean Sea (July 2023)
Daniele Grech, Giorgos Chatzigeorgiou, Emanuele Asciutto, Rigers Bakiu, Pietro Battaglia, Chaima Ben-Grira, Lovrenc Lipej, Borut Mavrič, Domen Trkov, 2023, izvirni znanstveni članek

Povzetek: This Collective Article presents new information about the occurrence of 23 marine taxa that belong to five Phyla: two Chlorophyta, one Annelida, six Mollusca, three Arthropoda, eleven Chordata (one Ascidiacea, one Elasmobranchii and nine Teleostei) and extending from the Western Mediterranean to the Levantine Sea. All these records were reported from nine countries from the western to the eastern Mediterranean Sea, with a broad biogeographical coverage as follows: Spain: first records of the sacoglossans Cyerce graeca and Placida tardyi for the Alboran Sea and first records of the nudibranch Marionia gemmii for the Mediterranean waters of Spain; first records of nudibranch Algarvia alba in the Mediterranean Sea. Italy: First report of the long-legged crab Paragalene longicrura, a further new Mediterranean record of the rare offshore rockfish Pontinus kuhlii, first documented record of the spiny butterfly ray Gymnura altavela in Sardinia (Tyrrhenian Sea), new record of the red‐spotted wrasse Lappanella fasciata from the Messina Strait, first documented record of the rarely observed brown moray Gymnothorax unicolor in the Ionian coast, first record of the colonial ascidian Botrylloides israeliensis, first record of the Morocco dentex Dentex maroccanus, first record of mottled shore crab Pachygrapsus maurus and of an adult specimen of barracudina Lestidiops sphyrenoides in the Adriatic Sea, and further new Mediterranean records of Ross worm Sabellaria spinulosa along the same coast. Tunisia: second record of smalleye squaretail Tetragonurus cuvieri from the African Mediterranean coast. Slovenia: first records of the sea slug Trapania graeffei and Melanochlamys wildpretii, with the last one also representing the northernmost finding of this species. Croatia: northernmost record of the endangered twaite shad Alosa fallax in the Adriatic coast. Albania: first records of the Mediterranean spearfish Tetrapturus belone. Türkiye: first record from the Aegean coasts for Türkiye of the green macroalgae Cladophora battersii and Valonia aegagropila. Israel: first record of the skeleton shrimp Caprella acanthifera in the Southeastern Mediterranean Sea. Syria: first record of the Smooth grenadier Nezumia aequalis from Syrian marine waters.
Ključne besede: rare species, gillrakers, Levantine Sea, Mediterranean Sea
Objavljeno v DiRROS: 12.07.2024; Ogledov: 43; Prenosov: 26
.pdf Celotno besedilo (7,33 MB)
Gradivo ima več datotek! Več...

Iskanje izvedeno v 1.96 sek.
Na vrh